Beam Therapeutics Inc (NASDAQ:BEAM)
| 29.60 Delayed Data As of Dec 01 |  +1.52 / +5.41%Today’s Change | 16.95 Today|||52-Week Range 51.60 | -24.32% Year-to-Date |
Latest BEAM News | Press Releases
| Wall Street Analysts Believe Beam Therapeutics Inc. (BEAM) Could Rally 81.29%: Here's is How to Trade Nov 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 28.08 |
| Today’s open | 27.91 |
| Day’s range | 27.05 - 29.60 |
| Volume | 75,911 |
| Average volume (3 months) | 1,163,849 |
| Market cap | $2.4B |
Data as of 4:00pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +28.45% |
| Earnings growth (this year) | -34.01% |
| Earnings growth (next 5 years) | +9.19% |
| Revenue growth (last year) | +17.51% |
| P/E ratio | NM |
| Price/Sales | 44.95 |
| Price/Book | 2.85 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | -$1.44 |
| Annual revenue (last year) | $60.9M |
| Annual profit (last year) | -$289.1M |
| Net profit margin | -474.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
